During one study in 27 prostate cancer patients with rising serum prostate-specific antigen [(PSA); indication for biochemical relapse of prostate cancer] levels, kinetics of PSA was monitored and used to determine the efficacy of the vaccination with moDC pulsed with allogeneic tumor cell lysate. The gene discussed is KLK3; the disease is Familial prostate cancer.